Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Filters applied: . Clear all
Page 1
Drug treatments for managing cystic fibrosis-related diabetes.
Onady GM, Stolfi A. Onady GM, et al. Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD004730. doi: 10.1002/14651858.CD004730.pub5. Cochrane Database Syst Rev. 2020. PMID: 33075159 Free PMC article.
BACKGROUND: The Cystic Fibrosis Foundation recommends both short-term and long-acting insulin therapy when cystic fibrosis-related diabetes (CFRD) has been diagnosed. ...MAIN RESULTS: The searches identified 29 trials (45 references). Four included trials provide results: …
BACKGROUND: The Cystic Fibrosis Foundation recommends both short-term and long-acting insulin therapy when cystic fibrosis-related di …
Insulin and oral agents for managing cystic fibrosis-related diabetes.
Onady GM, Stolfi A. Onady GM, et al. Cochrane Database Syst Rev. 2016 Apr 18;4:CD004730. doi: 10.1002/14651858.CD004730.pub4. Cochrane Database Syst Rev. 2016. PMID: 27087121 Updated. Review.
BACKGROUND: The Cystic Fibrosis Foundation recommends both short-term and long-acting insulin therapy when cystic fibrosis-related diabetes has been diagnosed. ...MAIN RESULTS: The searches identified 22 trials (34 references). Four trials (200 participants) are included: …
BACKGROUND: The Cystic Fibrosis Foundation recommends both short-term and long-acting insulin therapy when cystic fibrosis-related di …
Insulin and oral agents for managing cystic fibrosis-related diabetes.
Onady GM, Stolfi A. Onady GM, et al. Cochrane Database Syst Rev. 2013 Jul 26;(7):CD004730. doi: 10.1002/14651858.CD004730.pub3. Cochrane Database Syst Rev. 2013. PMID: 23893261 Updated. Review.
BACKGROUND: The Cystic Fibrosis Foundation recommends both short-term and long-acting insulin therapy when cystic fibrosis-related diabetes has been diagnosed. ...The long-term trial of insulin and repaglinide demonstrated no significant difference between treatment …
BACKGROUND: The Cystic Fibrosis Foundation recommends both short-term and long-acting insulin therapy when cystic fibrosis-related di …